Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus

Lupus Science and Medicine

Volumn 2, Issue 1, 2015, Pages

  Utset, Tammy O ^a   Baskaran, Amrutha ^b   Segal, Barbara M ^c   Trupin, Laura ^d   Ogale, Sarika ^e   Herberich, Ellen ^f   Kalunian, Kenneth ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GENENTECH INC   (United States)

^f Harris Interactive   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; AFRICAN; AGED; AMERICAN; ARTICLE; BRIEF COGNITIVE SYMPTOMS INDEX; BRIEF PAIN INVENTORY; COGNITION ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE DURATION; EMPLOYABILITY; FATIGUE; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY; SHORT FORM 12; SYSTEMIC LUPUS ERYTHEMATOSUS; WORK; WORK DISABILITY; WORK PRESENTEEISM;

EID: 84938970109     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2014-000058     Document Type: Article

References (42)

1. Faurshou M, Dreyer L, Kamper Al, et al. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken) 2010;62:873-80.
2. Stratta P, Canavese C, Ciccone G, et al. Relative survival of patients with lupus nephritis significantly improved over time in an Italian region: comment on the article by Faurschou et al. Arthritis Care Res. (Hoboken) 2010;62:1812-3. (editorial).
3. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308.
4. US Department of Labor, US Bureau of Labor Statistics. Women in the dataforce: A databook. May 2002, report 985 (URL expired).
5. Panopalis P, Clarke AE, Yelin E. The economic burden of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2012;26:695-704.
6. Campbell R Jr, Cooper GS, Gilkeson GS. The impact of systemic lupus erythematosus on employment. J Rheumatol 2009;36:2470-5.
7. Panopalis P, Julian L, Yazdany J, et al. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:1453-60.
8. Appenzeller S, Cendes F, Costallat LT. Cognitive impairment and employment status in systemic lupus erythematosus: A prospective longitudinal study. Arthritis Rheum 2009;61:680-7.
9. Baker K, Pope J, Fortin P, et al. Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors. Lupus 2009;18:1281-8.
10. Baker K, Pope J. Employment and work disability in systemic lupus erythematosus: A systemic review. Rheumatol 2009;48:281-4.
11. Yelin E, Trupin L, Katz P, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:56-63.
12. Sturfelt G, Nived O. Clinical inconsistency, benign course and normal employment rates in unselected systemic lupus erythematosus. Clin Exp Rheumatol 1985;3:303-10.
13. Stein H, Walters K, Dillon A, et al. Systemic lupus erythematosus-a medical and social profile. J Rheumatol 1986;13:570-6.
14. Sutcliffe N, Clarke AE, Taylor R, et al. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001;40:37-47.
15. Boomsma MM, Bijl M, Stegeman CA, et al. Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: A comparison with Wegener's granulomatosis. Arthritis Rheum 2002;47:196-201.
16. Partridge AJ, Karlson EW, Daltroy LH, et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 1997;40:2199-206.
17. Sutcliffe N, Clarke AE, Gordon C, et al. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999;38:1130-7.
18. Yelin E, Tonner C, Trupin L, et al. Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample. Arthritis Rheum 2009;61:247-58.
19. Almehed K, Carlsten H, Forsblad-d'Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J Rheumatol 2010;39:58-62.
20. Bultink IE, Turkstra F, Dijkmans BA, et al. High prevalence of unemployment in patients with systemic lupus erythematosus: Association with organ damage and health-related quality of life. J Rheumatol 2008;35:1053-7.
21. Utset TO, Chohan S, Booth SA, et al. Correlates of formal work disability in an urban university systemic lupus erythematosus practice. J Rheumatol 2008;35:1046-52.
22. Garris C, Oglesby A, Sulcs E, et al. Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States. Lupus 2013;22:1077-86.
23. Gordon C, Isenberg D, Lerstrom K, et al. The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: A European patient-driven online survey. Rheumatology (Oxford) 2013;52:2292-301.
24. Drenkard C, Bao G, Dennis G, et al. The burden of systemic lupus erythematosus on employment and work productivity: Data from a large cohort in the Southeastern United States. Arthritis Care Res (Hoboken) 2014;66:878-87.
25. Utset TO, Fink J, Doninger NA. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 2006;33:531-8.
26. Clarke AE, Esdaile JM, Bloch DA, et al. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993;36:1548-59.
27. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
28. Bunin GR, Vardhanabhuti S, Lin A, et al. Practical and analytical aspects of using friend controls in case-control studies: experience from a case-control study of childhood cancer. Paediatr Perinat Epidemiol 2011;25:402-12.
29. Wacholder S, Silverman DT, McLaughlin JK, et al. Selection of Controls in Case-Control Studies II. Types of Controls. Am J of Epidemiol 1992;135:1029-41.
30. Gladman D, Ginzler E, Goldsmith C, et al. Systemic Lupus International Collaborative Clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol 1992;19:1820-1.
31. Katz JN, Chang LC, Sangha O, et al. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
32. Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: A new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003;49:156-63.
33. Kessler RC, Barber C, Beck A, et al. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med 2003;45:156-74.
34. Wang PS, Beck A, Berglund P, et al. Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med 2003;45:1303-11.
35. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003;1:79.
36. Andresen EM, Malmgren JA, Carter WB, et al. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994;10:77-84.
37. Irwin M, Artin KH, Oxman MN. Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med 1999;159:1701-4.
38. Pincus TSC, Callahan LF. A self-report cognitive symptoms inventory to assess patients with rheumatic diseases: results in eosinophilia-myalgia syndrome (EMS), fibromyalgia, rheumatoid arthritis (RA), and other rheumatic diseases [abstract]. Arthritis Rheum 1996;39(Suppl 9):S261.
39. Yu EB, Shikiar R, Howard K, et al. Validation of LUP-QOL: A lupus-specific measure of health-related quality of life (HRQL) [abstract]. Ann Rheum Dis 2006;65(Suppl II):601.
40. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
41. Keller S, Bann CM, Dodd SL, et al. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004;20:309-18.
42. US Census Bureau. Labor force, employment and earnings and employed civilians by occupation, sex, race, and Hispanic origin: 1983 and 1999. Statistic Abstract of the United States: 2000: 401 and Table 660, Washington DC: US GPO, 2001 (URL expired).